SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-017762
Filing Date
2019-09-11
Accepted
2019-09-11 17:08:38
Documents
60
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0319_inspyrtherap.htm 10-Q 973590
2 CERTIFICATION f10q0319ex31-1_inspyr.htm EX-31.1 9529
3 CERTIFICATION f10q0319ex31-2_inspyr.htm EX-31.2 9728
4 CERTIFICATION f10q0319ex32-1_inspyr.htm EX-32.1 7432
5 CERTIFICATION f10q0319ex32-2_inspyr.htm EX-32.2 7690
  Complete submission text file 0001213900-19-017762.txt   2981360

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE nspx-20190331.xml EX-101.INS 332034
7 XBRL SCHEMA FILE nspx-20190331.xsd EX-101.SCH 37068
8 XBRL CALCULATION FILE nspx-20190331_cal.xml EX-101.CAL 36073
9 XBRL DEFINITION FILE nspx-20190331_def.xml EX-101.DEF 117731
10 XBRL LABEL FILE nspx-20190331_lab.xml EX-101.LAB 255593
11 XBRL PRESENTATION FILE nspx-20190331_pre.xml EX-101.PRE 196218
Mailing Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258
Business Address 2511 N LOOP 1604 W SUITE 204 SAN ANTONIO TX 78258 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55331 | Film No.: 191088977
SIC: 2834 Pharmaceutical Preparations